Dr. Reddy’s to launch ‘Molflu’ capsules for Covid 19

Global markets are showing mixed cues. The US markets did well. However, Nasdaq saw a correction. The Asian markets are showing mixed trends.

The Omicron impact on labour supply in the US is visible. Several workers leave their jobs because of the pandemic. The US auto sales were good but they still have to achieve the pre-pandemic level.

As per the ICRA report, the Indian pharma industry may achieve 9 to 11 percent growth in FY 2021-22. 

Dr. Reddy’s will launch Molnupiravir capsules under the brand name ‘Molflu’.